Subtype
Non-Invasive Bladder Urothelial Neoplasm
CI-CAN-00006139Explore in graph →
Non-malignant3 active trials
- NCIt
- C158374
Loading cancer entity…
Subtype
CI-CAN-00006139Explore in graph →
Clinical trials
10 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05375903 | A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC) | completed | Phase 1 | 51 | UroGen Pharma Ltd.INDUSTRY | 3 | Jan 14, 2026 | clinicaltrials |
Data updated 22 days agoSource updated Jan 14, 2026source: clinicaltrials